This Blood Cancer Awareness Month, we have celebrated the multidisciplinary teams who support patients throughout every stage of their blood cancer journey, from diagnosis and treatment to research, rehabilitation and long-term care.
Across our spotlight series, one message emerged time and again: no one profession works alone. Clinical scientists, nurses, physiotherapists, pharmacists, doctors, researchers, laboratory staff and many others all play a vital role in delivering the best possible outcomes for patients. From shared decision-making in multidisciplinary meetings to the delivery of complex treatments and clinical trials, collaboration is at the heart of modern blood cancer care.
There was also a strong sense of optimism for the future. Many of those featured reflected on the rapid pace of progress in blood cancer research and treatment. From CAR-T cell therapies and bispecific antibodies to increasingly personalised approaches to care, advances that once seemed out of reach are already transforming outcomes for patients. As Research Nurse Manager Almudena Duran Rosas noted, research is advancing at an extraordinary pace and bringing real hope to patients and families, while Specialist Physiotherapist Emma Nicholls described CAR-T therapies as transforming treatment options for many people. Consultant Haematologist David Tucker highlighted the impact of bispecific antibodies, which are changing the way we fight cancer.
Yet alongside these scientific advances, our spotlight contributors consistently returned to what matters most: supporting patients as individuals. Whether helping someone understand a diagnosis, access a clinical trial, recover after a stem cell transplant or navigate treatment, every member of the team contributes to compassionate, person-centred care.
As BSH President Dr John Ashcroft reflects:
“We want every one of the 40,000 people faced with a blood cancer diagnosis this year to be able to access the same expertise whether it be in a major specialist centre or a district general hospital – in a big city or in a rural area. Our members across the whole blood cancer workforce are truly dedicated. However, with ever increasing workloads and increasingly complex treatment pathways we need to recruit and retain the best people to ensure we always have the tools, expertise and resource to do our best work to support patients across all aspects of their treatment journey. There is an urgent and ever increasing need to protect and increase research capacity, develop infrastructure and improve working conditions for our clinical teams to ensure they can deliver innovation and high-quality patient care. This Blood Cancer Awareness Month I want to celebrate all of you working in this field in the clinic, in the lab, with patients or behind the scenes. The whole team matters. On behalf of BSH I would like to thank you all.”